India Exchange Filings

Titan Biotech Q2 FY27 Earnings and Board Meeting Highlights

Titan Biotech Ltd approves Q2 FY27 results, with revenue up 31% YoY to ₹76.46 crore

  • Q2 standalone net profit rose 65.1% YoY to ₹11.33 crore; consolidated net profit increased 61.6% to ₹12.55 crore.
  • Revenue from operations grew 29.2% sequentially; standalone and consolidated profit rose 19.8% and 15.6% QoQ, respectively.
  • Statutory auditors’ limited-review reports carried no modified conclusion or qualification; no exceptional items were reported.

Original Filing

This is an automated summary of a public document. Always check the original before relying on it.